483
Peter James Ostler, MDPeter James Ostler, MD – FDA 483, Aug 22, 2025
Record Details
An FDA inspection of Peter James Ostler, MD, a clinical investigator in Northwood, Middlesex, United Kingdom, revealed a significant failure to adhere to study protocol requirements. The inspection found a pattern of not reporting non-serious adverse events to the sponsor in a timely manner. Specifically, at least 25 unreported adverse events were identified across five of the ten subject records reviewed for protocol CO-338-063.
View Company Profile
ID · c02d4126-c774-40cb-bf1a-45ff4db094c7
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.